You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Study to Assess the Pharmacokinetics of Pioglitazone in Healthy Subjects when Administered Alone and in Combination with Fostamatinib 100 mg Twice Daily
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Generic Name
- FOSTAMATIN
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D4300C00014
- Study Id
- D4300C00014
- ClinicalTrials.gov ID
- NCT01309854
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
